 Patrick Carry
Concepts (418)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Scoliosis | 12 | 2024 | 206 | 3.500 |
Why?
| | DNA Methylation | 7 | 2024 | 610 | 2.150 |
Why?
| | Islets of Langerhans | 5 | 2024 | 795 | 1.820 |
Why?
| | Acetabulum | 17 | 2024 | 103 | 1.750 |
Why?
| | Hip Dislocation, Congenital | 11 | 2023 | 37 | 1.650 |
Why?
| | Autoimmunity | 7 | 2024 | 867 | 1.510 |
Why?
| | Humeral Fractures | 8 | 2022 | 48 | 1.170 |
Why?
| | Diabetes Mellitus, Type 1 | 10 | 2024 | 3629 | 1.160 |
Why?
| | Spinal Fusion | 6 | 2022 | 224 | 1.150 |
Why?
| | Fractures, Bone | 8 | 2023 | 418 | 1.040 |
Why?
| | Orthopedic Procedures | 10 | 2020 | 228 | 1.000 |
Why?
| | Hip Dislocation | 9 | 2024 | 48 | 0.970 |
Why?
| | Adolescent | 64 | 2025 | 20374 | 0.970 |
Why?
| | Osteotomy | 11 | 2024 | 164 | 0.960 |
Why?
| | Hip Joint | 11 | 2022 | 159 | 0.900 |
Why?
| | Child | 63 | 2024 | 20961 | 0.850 |
Why?
| | Genome-Wide Association Study | 4 | 2024 | 1341 | 0.830 |
Why?
| | Propensity Score | 3 | 2023 | 265 | 0.810 |
Why?
| | Disease Progression | 5 | 2024 | 2639 | 0.790 |
Why?
| | Kyphosis | 1 | 2022 | 36 | 0.790 |
Why?
| | Blood Loss, Surgical | 3 | 2021 | 91 | 0.770 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 6 | 2019 | 125 | 0.760 |
Why?
| | Ultrasonic Therapy | 1 | 2021 | 12 | 0.740 |
Why?
| | Brain Concussion | 6 | 2025 | 547 | 0.740 |
Why?
| | Radiography | 21 | 2021 | 874 | 0.730 |
Why?
| | Seroconversion | 1 | 2021 | 46 | 0.720 |
Why?
| | Twins, Monozygotic | 1 | 2021 | 208 | 0.690 |
Why?
| | Diseases in Twins | 1 | 2021 | 175 | 0.680 |
Why?
| | Semicircular Canals | 1 | 2020 | 29 | 0.670 |
Why?
| | Autoantibodies | 3 | 2024 | 1473 | 0.660 |
Why?
| | Athletic Injuries | 7 | 2025 | 517 | 0.660 |
Why?
| | Femoracetabular Impingement | 5 | 2020 | 34 | 0.650 |
Why?
| | Phospholipids | 1 | 2021 | 211 | 0.650 |
Why?
| | Return to Sport | 6 | 2025 | 91 | 0.650 |
Why?
| | Retrospective Studies | 54 | 2024 | 14675 | 0.650 |
Why?
| | Postoperative Complications | 18 | 2020 | 2511 | 0.640 |
Why?
| | Humans | 107 | 2025 | 130305 | 0.620 |
Why?
| | Ultrasonography | 6 | 2022 | 731 | 0.600 |
Why?
| | Surgeons | 1 | 2022 | 279 | 0.590 |
Why?
| | Upper Extremity | 2 | 2023 | 96 | 0.590 |
Why?
| | Health Status | 1 | 2023 | 756 | 0.580 |
Why?
| | Joint Instability | 6 | 2022 | 181 | 0.570 |
Why?
| | Female | 75 | 2025 | 68842 | 0.560 |
Why?
| | Fracture Fixation | 3 | 2015 | 82 | 0.550 |
Why?
| | Child, Preschool | 21 | 2024 | 10514 | 0.550 |
Why?
| | Male | 75 | 2025 | 63748 | 0.550 |
Why?
| | Algorithms | 2 | 2023 | 1638 | 0.530 |
Why?
| | Arteries | 1 | 2018 | 269 | 0.510 |
Why?
| | Fracture Fixation, Intramedullary | 4 | 2022 | 63 | 0.500 |
Why?
| | Femur | 5 | 2023 | 247 | 0.500 |
Why?
| | Clavicle | 3 | 2014 | 33 | 0.490 |
Why?
| | Tibial Fractures | 3 | 2023 | 73 | 0.490 |
Why?
| | Pain, Postoperative | 5 | 2018 | 230 | 0.460 |
Why?
| | Anterior Cruciate Ligament Injuries | 4 | 2019 | 140 | 0.450 |
Why?
| | Lower Extremity | 3 | 2023 | 409 | 0.440 |
Why?
| | Femur Head | 3 | 2021 | 38 | 0.430 |
Why?
| | Treatment Outcome | 31 | 2023 | 10341 | 0.410 |
Why?
| | Oxylipins | 3 | 2023 | 31 | 0.410 |
Why?
| | Reoperation | 7 | 2024 | 558 | 0.400 |
Why?
| | Snow Sports | 1 | 2012 | 2 | 0.400 |
Why?
| | Head Protective Devices | 1 | 2012 | 17 | 0.390 |
Why?
| | Femur Head Necrosis | 3 | 2016 | 8 | 0.390 |
Why?
| | Case-Control Studies | 9 | 2023 | 3369 | 0.390 |
Why?
| | Fracture Fixation, Internal | 7 | 2022 | 222 | 0.370 |
Why?
| | Epigenesis, Genetic | 4 | 2024 | 620 | 0.360 |
Why?
| | Patellofemoral Pain Syndrome | 1 | 2010 | 6 | 0.350 |
Why?
| | Epiphyses | 7 | 2021 | 20 | 0.350 |
Why?
| | Pronation | 1 | 2010 | 10 | 0.350 |
Why?
| | Patellofemoral Joint | 1 | 2010 | 8 | 0.350 |
Why?
| | Insulin | 2 | 2021 | 2322 | 0.340 |
Why?
| | Osteogenesis Imperfecta | 2 | 2020 | 14 | 0.340 |
Why?
| | Bone Nails | 4 | 2019 | 67 | 0.330 |
Why?
| | Magnetic Resonance Imaging | 6 | 2022 | 3380 | 0.330 |
Why?
| | Parent-Child Relations | 1 | 2012 | 254 | 0.320 |
Why?
| | Manipulation, Orthopedic | 3 | 2019 | 7 | 0.310 |
Why?
| | Severity of Illness Index | 7 | 2021 | 2785 | 0.310 |
Why?
| | Clubfoot | 2 | 2019 | 10 | 0.280 |
Why?
| | Casts, Surgical | 2 | 2019 | 32 | 0.280 |
Why?
| | Slipped Capital Femoral Epiphyses | 2 | 2018 | 6 | 0.270 |
Why?
| | Risk Factors | 16 | 2023 | 9865 | 0.260 |
Why?
| | Spine | 2 | 2018 | 158 | 0.260 |
Why?
| | Young Adult | 17 | 2024 | 12404 | 0.260 |
Why?
| | Cadaver | 3 | 2022 | 336 | 0.260 |
Why?
| | Cohort Studies | 8 | 2021 | 5431 | 0.260 |
Why?
| | Sports | 2 | 2022 | 226 | 0.260 |
Why?
| | Prevalence | 4 | 2022 | 2576 | 0.260 |
Why?
| | Surgical Wound Infection | 3 | 2018 | 292 | 0.250 |
Why?
| | Clinical Protocols | 2 | 2018 | 258 | 0.250 |
Why?
| | Radiation Dosage | 2 | 2024 | 162 | 0.240 |
Why?
| | Charcot-Marie-Tooth Disease | 2 | 2016 | 22 | 0.240 |
Why?
| | Infant | 13 | 2023 | 9049 | 0.240 |
Why?
| | Athletes | 5 | 2022 | 411 | 0.240 |
Why?
| | Genetic Predisposition to Disease | 3 | 2023 | 2282 | 0.240 |
Why?
| | Tibia | 2 | 2023 | 184 | 0.230 |
Why?
| | Tibial Meniscus Injuries | 2 | 2015 | 45 | 0.230 |
Why?
| | Range of Motion, Articular | 7 | 2022 | 387 | 0.230 |
Why?
| | Cartilage, Articular | 2 | 2020 | 297 | 0.230 |
Why?
| | Proprioception | 1 | 2024 | 26 | 0.230 |
Why?
| | Elbow Joint | 3 | 2019 | 65 | 0.220 |
Why?
| | Sternoclavicular Joint | 2 | 2014 | 9 | 0.220 |
Why?
| | Biomechanical Phenomena | 6 | 2022 | 786 | 0.220 |
Why?
| | Dizziness | 1 | 2024 | 80 | 0.220 |
Why?
| | Radiation Exposure | 1 | 2024 | 48 | 0.220 |
Why?
| | Odds Ratio | 8 | 2019 | 1027 | 0.220 |
Why?
| | Orthotic Devices | 3 | 2022 | 28 | 0.220 |
Why?
| | Time Factors | 13 | 2021 | 6615 | 0.210 |
Why?
| | HLA-DR4 Antigen | 2 | 2021 | 79 | 0.210 |
Why?
| | HLA-DR3 Antigen | 2 | 2021 | 81 | 0.210 |
Why?
| | Adult | 20 | 2024 | 35711 | 0.210 |
Why?
| | Cervical Vertebrae | 1 | 2024 | 130 | 0.210 |
Why?
| | Follow-Up Studies | 11 | 2024 | 4961 | 0.210 |
Why?
| | Humerus | 2 | 2022 | 41 | 0.210 |
Why?
| | Growth Plate | 2 | 2023 | 36 | 0.210 |
Why?
| | Tomography, X-Ray Computed | 3 | 2019 | 2551 | 0.210 |
Why?
| | Meniere Disease | 1 | 2023 | 31 | 0.200 |
Why?
| | Gait Disorders, Neurologic | 1 | 2022 | 44 | 0.200 |
Why?
| | Ligaments, Articular | 1 | 2022 | 59 | 0.200 |
Why?
| | Wrist Joint | 1 | 2022 | 63 | 0.190 |
Why?
| | Hip Fractures | 1 | 2023 | 82 | 0.190 |
Why?
| | Spinal Fractures | 1 | 2023 | 81 | 0.190 |
Why?
| | Orthopedic Surgeons | 1 | 2022 | 26 | 0.190 |
Why?
| | Radius Fractures | 1 | 2022 | 58 | 0.190 |
Why?
| | Ankle Fractures | 1 | 2022 | 19 | 0.190 |
Why?
| | Migraine Disorders | 1 | 2023 | 91 | 0.190 |
Why?
| | Legg-Calve-Perthes Disease | 1 | 2021 | 4 | 0.190 |
Why?
| | Deafness | 1 | 2023 | 80 | 0.190 |
Why?
| | Quadriceps Muscle | 3 | 2022 | 129 | 0.190 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2021 | 45 | 0.190 |
Why?
| | Selection Bias | 1 | 2021 | 37 | 0.190 |
Why?
| | Bone Plates | 2 | 2022 | 88 | 0.180 |
Why?
| | Orthognathic Surgical Procedures | 1 | 2001 | 5 | 0.180 |
Why?
| | Age Factors | 7 | 2021 | 3153 | 0.180 |
Why?
| | Neck Muscles | 1 | 2021 | 17 | 0.180 |
Why?
| | Cerebral Palsy | 1 | 2022 | 96 | 0.180 |
Why?
| | Incidence | 8 | 2023 | 2657 | 0.180 |
Why?
| | Prosthesis Fitting | 1 | 2020 | 16 | 0.180 |
Why?
| | Lumbar Vertebrae | 1 | 2022 | 224 | 0.170 |
Why?
| | Suture Techniques | 2 | 2019 | 121 | 0.170 |
Why?
| | Monitoring, Intraoperative | 2 | 2016 | 44 | 0.170 |
Why?
| | Probability | 1 | 2021 | 314 | 0.170 |
Why?
| | Arthralgia | 2 | 2020 | 52 | 0.170 |
Why?
| | Longitudinal Studies | 2 | 2025 | 2691 | 0.170 |
Why?
| | Pelvic Bones | 1 | 2023 | 152 | 0.170 |
Why?
| | Bias | 1 | 2021 | 197 | 0.170 |
Why?
| | Proportional Hazards Models | 2 | 2021 | 1235 | 0.170 |
Why?
| | Muscle Strength | 2 | 2021 | 308 | 0.170 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 144 | 0.170 |
Why?
| | Patella | 1 | 2019 | 22 | 0.170 |
Why?
| | Intraoperative Complications | 1 | 2001 | 134 | 0.170 |
Why?
| | Recreation | 1 | 2019 | 21 | 0.170 |
Why?
| | Play and Playthings | 1 | 2019 | 34 | 0.170 |
Why?
| | Histology | 1 | 2019 | 4 | 0.160 |
Why?
| | Bone-Patellar Tendon-Bone Grafting | 1 | 2019 | 11 | 0.160 |
Why?
| | Education, Professional | 1 | 2019 | 18 | 0.160 |
Why?
| | Health Occupations | 1 | 2019 | 29 | 0.160 |
Why?
| | Equipment Failure | 1 | 2019 | 112 | 0.150 |
Why?
| | Gene Frequency | 1 | 2020 | 504 | 0.150 |
Why?
| | Tendons | 1 | 2019 | 127 | 0.150 |
Why?
| | Computer-Assisted Instruction | 1 | 2019 | 60 | 0.150 |
Why?
| | Prospective Studies | 8 | 2025 | 7131 | 0.150 |
Why?
| | Logistic Models | 5 | 2017 | 1980 | 0.150 |
Why?
| | Pattern Recognition, Visual | 1 | 2019 | 95 | 0.150 |
Why?
| | Interleukins | 1 | 2020 | 247 | 0.150 |
Why?
| | Anesthesia, Local | 1 | 2018 | 17 | 0.150 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2018 | 11 | 0.150 |
Why?
| | Prader-Willi Syndrome | 1 | 2018 | 27 | 0.150 |
Why?
| | Genetic Association Studies | 1 | 2020 | 359 | 0.150 |
Why?
| | Femoral Nerve | 1 | 2018 | 16 | 0.150 |
Why?
| | Bone Malalignment | 1 | 2017 | 15 | 0.140 |
Why?
| | Analgesia, Epidural | 1 | 2018 | 23 | 0.140 |
Why?
| | Arthroscopy | 2 | 2020 | 211 | 0.140 |
Why?
| | CpG Islands | 3 | 2023 | 152 | 0.140 |
Why?
| | Quantitative Trait Loci | 1 | 2020 | 356 | 0.140 |
Why?
| | Meningomyelocele | 1 | 2018 | 59 | 0.140 |
Why?
| | Sciatic Nerve | 1 | 2018 | 60 | 0.140 |
Why?
| | Collagen | 1 | 2020 | 437 | 0.140 |
Why?
| | Femoral Fractures | 1 | 2018 | 74 | 0.140 |
Why?
| | Antibiotic Prophylaxis | 1 | 2018 | 105 | 0.140 |
Why?
| | Nerve Block | 1 | 2018 | 69 | 0.140 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 430 | 0.130 |
Why?
| | Learning Curve | 1 | 2017 | 68 | 0.130 |
Why?
| | Epiphyses, Slipped | 1 | 2016 | 4 | 0.130 |
Why?
| | Immunity, Innate | 1 | 2022 | 814 | 0.130 |
Why?
| | Cumulative Trauma Disorders | 1 | 2016 | 41 | 0.130 |
Why?
| | Open Fracture Reduction | 1 | 2016 | 31 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 563 | 0.130 |
Why?
| | Substance-Related Disorders | 1 | 2025 | 1023 | 0.130 |
Why?
| | Metabolomics | 1 | 2021 | 599 | 0.130 |
Why?
| | Depression | 1 | 2025 | 1298 | 0.130 |
Why?
| | Pain | 1 | 2022 | 765 | 0.130 |
Why?
| | ST Elevation Myocardial Infarction | 1 | 2016 | 53 | 0.130 |
Why?
| | Postoperative Hemorrhage | 1 | 2016 | 86 | 0.120 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5083 | 0.120 |
Why?
| | Electrocardiography | 2 | 2016 | 615 | 0.120 |
Why?
| | Radius | 1 | 2015 | 36 | 0.120 |
Why?
| | Shoulder Fractures | 1 | 2015 | 12 | 0.120 |
Why?
| | Predictive Value of Tests | 5 | 2020 | 1974 | 0.120 |
Why?
| | Forecasting | 1 | 2016 | 364 | 0.120 |
Why?
| | Nonprescription Drugs | 1 | 2015 | 69 | 0.120 |
Why?
| | Soft Tissue Injuries | 1 | 2015 | 37 | 0.120 |
Why?
| | United States | 10 | 2025 | 14110 | 0.110 |
Why?
| | Elective Surgical Procedures | 1 | 2016 | 164 | 0.110 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2014 | 38 | 0.110 |
Why?
| | Menisci, Tibial | 1 | 2014 | 59 | 0.110 |
Why?
| | Unnecessary Procedures | 1 | 2015 | 48 | 0.110 |
Why?
| | Bone Marrow Transplantation | 1 | 2015 | 271 | 0.110 |
Why?
| | Practice Patterns, Physicians' | 2 | 2015 | 1294 | 0.110 |
Why?
| | Autografts | 1 | 2014 | 42 | 0.110 |
Why?
| | Caregivers | 1 | 2022 | 826 | 0.110 |
Why?
| | Long QT Syndrome | 1 | 2015 | 68 | 0.110 |
Why?
| | Bone Diseases | 1 | 2014 | 60 | 0.110 |
Why?
| | Venous Thrombosis | 1 | 2016 | 161 | 0.110 |
Why?
| | Patient Compliance | 1 | 2018 | 565 | 0.110 |
Why?
| | Diet | 1 | 2021 | 1214 | 0.110 |
Why?
| | Allografts | 1 | 2014 | 139 | 0.110 |
Why?
| | Prescription Drugs | 1 | 2015 | 116 | 0.110 |
Why?
| | Obesity | 3 | 2015 | 2869 | 0.110 |
Why?
| | Cartilage | 1 | 2015 | 181 | 0.110 |
Why?
| | Joint Dislocations | 1 | 2014 | 64 | 0.110 |
Why?
| | Exercise | 1 | 2025 | 1941 | 0.110 |
Why?
| | Pulmonary Embolism | 1 | 2016 | 211 | 0.110 |
Why?
| | Risk Assessment | 7 | 2017 | 3310 | 0.110 |
Why?
| | Shoulder Dislocation | 1 | 2014 | 49 | 0.110 |
Why?
| | Injury Severity Score | 3 | 2023 | 513 | 0.100 |
Why?
| | Chi-Square Distribution | 4 | 2015 | 517 | 0.100 |
Why?
| | Clinical Competence | 2 | 2017 | 1029 | 0.100 |
Why?
| | Intra-Articular Fractures | 1 | 2012 | 19 | 0.100 |
Why?
| | Bupivacaine | 1 | 2012 | 32 | 0.100 |
Why?
| | Body Mass Index | 3 | 2016 | 2268 | 0.100 |
Why?
| | Kaplan-Meier Estimate | 4 | 2016 | 869 | 0.100 |
Why?
| | Pediatrics | 1 | 2020 | 1063 | 0.100 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2074 | 0.100 |
Why?
| | Amides | 1 | 2012 | 91 | 0.100 |
Why?
| | Bone and Bones | 1 | 2014 | 303 | 0.100 |
Why?
| | Anemia, Sickle Cell | 1 | 2015 | 274 | 0.100 |
Why?
| | Multivariate Analysis | 4 | 2017 | 1510 | 0.100 |
Why?
| | Knee Joint | 3 | 2022 | 367 | 0.090 |
Why?
| | Treatment Failure | 3 | 2019 | 351 | 0.090 |
Why?
| | Graft Survival | 1 | 2014 | 543 | 0.090 |
Why?
| | Guideline Adherence | 1 | 2015 | 534 | 0.090 |
Why?
| | Operative Time | 3 | 2017 | 121 | 0.090 |
Why?
| | Recovery of Function | 4 | 2016 | 646 | 0.090 |
Why?
| | Linear Models | 3 | 2021 | 826 | 0.090 |
Why?
| | Gait | 2 | 2025 | 286 | 0.090 |
Why?
| | Reproducibility of Results | 4 | 2020 | 3069 | 0.090 |
Why?
| | Craniocerebral Trauma | 1 | 2012 | 154 | 0.090 |
Why?
| | Aged, 80 and over | 2 | 2021 | 7128 | 0.090 |
Why?
| | Emergency Medical Services | 1 | 2016 | 564 | 0.080 |
Why?
| | North America | 1 | 2011 | 290 | 0.080 |
Why?
| | Analgesics, Opioid | 1 | 2018 | 921 | 0.080 |
Why?
| | Torque | 2 | 2021 | 84 | 0.080 |
Why?
| | Trauma Centers | 2 | 2022 | 410 | 0.080 |
Why?
| | Sex Factors | 3 | 2021 | 1965 | 0.080 |
Why?
| | Data Collection | 1 | 2012 | 654 | 0.080 |
Why?
| | Health Care Surveys | 1 | 2011 | 564 | 0.080 |
Why?
| | Mice | 2 | 2023 | 16832 | 0.080 |
Why?
| | Neuromuscular Diseases | 1 | 2010 | 106 | 0.080 |
Why?
| | Facial Bones | 2 | 2001 | 31 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2440 | 0.070 |
Why?
| | Anti-Bacterial Agents | 1 | 2018 | 1712 | 0.070 |
Why?
| | Postoperative Care | 3 | 2015 | 246 | 0.070 |
Why?
| | Equipment Failure Analysis | 2 | 2020 | 132 | 0.070 |
Why?
| | Observer Variation | 2 | 2018 | 324 | 0.070 |
Why?
| | Self Report | 2 | 2025 | 802 | 0.070 |
Why?
| | Regression Analysis | 2 | 2019 | 991 | 0.070 |
Why?
| | Bone Transplantation | 2 | 2019 | 105 | 0.070 |
Why?
| | Hemodilution | 2 | 1996 | 9 | 0.060 |
Why?
| | Equipment Design | 2 | 2019 | 526 | 0.060 |
Why?
| | Patient Care Team | 1 | 2010 | 612 | 0.060 |
Why?
| | Prognosis | 3 | 2020 | 3830 | 0.060 |
Why?
| | Infant, Newborn | 4 | 2019 | 5741 | 0.060 |
Why?
| | Animals | 2 | 2023 | 35076 | 0.050 |
Why?
| | Knee Injuries | 2 | 2015 | 99 | 0.050 |
Why?
| | Vestibule, Labyrinth | 1 | 2024 | 66 | 0.050 |
Why?
| | Fluoroscopy | 1 | 2024 | 170 | 0.050 |
Why?
| | GTPase-Activating Proteins | 1 | 2023 | 82 | 0.050 |
Why?
| | Reaction Time | 1 | 2025 | 407 | 0.050 |
Why?
| | Operating Rooms | 1 | 2024 | 109 | 0.050 |
Why?
| | Middle Aged | 7 | 2022 | 31322 | 0.050 |
Why?
| | X-Rays | 1 | 2022 | 33 | 0.050 |
Why?
| | Vertigo | 1 | 2023 | 38 | 0.050 |
Why?
| | Pain Measurement | 2 | 2018 | 491 | 0.050 |
Why?
| | Colorado | 3 | 2018 | 4471 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2023 | 123 | 0.050 |
Why?
| | Pelvis | 1 | 2023 | 103 | 0.050 |
Why?
| | Patient Satisfaction | 2 | 2018 | 647 | 0.050 |
Why?
| | Physical Therapy Modalities | 2 | 2015 | 293 | 0.050 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 146 | 0.050 |
Why?
| | Fracture Healing | 1 | 2022 | 78 | 0.050 |
Why?
| | Anatomic Variation | 1 | 2021 | 3 | 0.050 |
Why?
| | Catheters | 1 | 2022 | 67 | 0.050 |
Why?
| | Epidemiologic Studies | 1 | 2021 | 66 | 0.050 |
Why?
| | Peripheral Nerves | 1 | 2022 | 67 | 0.050 |
Why?
| | Standard of Care | 1 | 2022 | 72 | 0.050 |
Why?
| | Preanesthetic Medication | 1 | 2001 | 3 | 0.050 |
Why?
| | Chin | 1 | 2001 | 5 | 0.050 |
Why?
| | Osteotomy, Le Fort | 1 | 2001 | 3 | 0.050 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2001 | 11 | 0.050 |
Why?
| | Pulmonary Atelectasis | 1 | 2001 | 14 | 0.050 |
Why?
| | Linoleic Acid | 1 | 2021 | 41 | 0.050 |
Why?
| | Malocclusion | 1 | 2001 | 25 | 0.050 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2021 | 62 | 0.050 |
Why?
| | Muscle Strength Dynamometer | 1 | 2021 | 22 | 0.050 |
Why?
| | Arachidonic Acid | 1 | 2021 | 115 | 0.050 |
Why?
| | Osteogenesis, Distraction | 1 | 2001 | 15 | 0.040 |
Why?
| | Work | 1 | 2020 | 18 | 0.040 |
Why?
| | Anesthesia, General | 1 | 2001 | 53 | 0.040 |
Why?
| | Musculoskeletal System | 1 | 2021 | 46 | 0.040 |
Why?
| | Glutamate Decarboxylase | 1 | 2021 | 166 | 0.040 |
Why?
| | Docosahexaenoic Acids | 1 | 2021 | 83 | 0.040 |
Why?
| | Blood | 1 | 2001 | 101 | 0.040 |
Why?
| | Emergency Service, Hospital | 2 | 2023 | 1986 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 48 | 0.040 |
Why?
| | Functional Laterality | 1 | 2020 | 218 | 0.040 |
Why?
| | Patellar Ligament | 1 | 2019 | 25 | 0.040 |
Why?
| | Foreign Bodies | 1 | 2001 | 104 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2023 | 572 | 0.040 |
Why?
| | Epidemiological Monitoring | 1 | 2019 | 50 | 0.040 |
Why?
| | Athletic Performance | 1 | 2020 | 77 | 0.040 |
Why?
| | Fetal Blood | 1 | 2021 | 316 | 0.040 |
Why?
| | Students | 1 | 2025 | 584 | 0.040 |
Why?
| | Educational Status | 1 | 2022 | 467 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2021 | 491 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2021 | 773 | 0.040 |
Why?
| | Sutures | 1 | 2019 | 53 | 0.040 |
Why?
| | Ligaments | 1 | 2019 | 54 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 139 | 0.040 |
Why?
| | Isometric Contraction | 1 | 2021 | 186 | 0.040 |
Why?
| | Students, Health Occupations | 1 | 2019 | 28 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 453 | 0.040 |
Why?
| | Eye Movements | 1 | 2019 | 58 | 0.040 |
Why?
| | Anterior Cruciate Ligament | 1 | 2019 | 82 | 0.040 |
Why?
| | Hospitals | 1 | 2023 | 641 | 0.040 |
Why?
| | Comorbidity | 2 | 2015 | 1555 | 0.040 |
Why?
| | Professional Competence | 1 | 2019 | 96 | 0.040 |
Why?
| | Video Recording | 1 | 2019 | 163 | 0.040 |
Why?
| | Random Allocation | 1 | 2019 | 353 | 0.040 |
Why?
| | Breast Feeding | 1 | 2021 | 427 | 0.040 |
Why?
| | Thoracic Vertebrae | 1 | 2018 | 73 | 0.040 |
Why?
| | Risk Management | 1 | 2018 | 92 | 0.030 |
Why?
| | Organ Size | 1 | 2018 | 450 | 0.030 |
Why?
| | Calcium | 1 | 2023 | 1189 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2018 | 238 | 0.030 |
Why?
| | Device Removal | 1 | 2018 | 143 | 0.030 |
Why?
| | Age of Onset | 1 | 2018 | 499 | 0.030 |
Why?
| | Intestinal Fistula | 1 | 1996 | 15 | 0.030 |
Why?
| | Ileostomy | 1 | 1996 | 20 | 0.030 |
Why?
| | Intracranial Pressure | 1 | 2016 | 46 | 0.030 |
Why?
| | Ribs | 1 | 2015 | 33 | 0.030 |
Why?
| | Inservice Training | 1 | 2016 | 113 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1300 | 0.030 |
Why?
| | Missouri | 1 | 2015 | 68 | 0.030 |
Why?
| | Methylprednisolone | 1 | 1996 | 83 | 0.030 |
Why?
| | Patient Outcome Assessment | 1 | 2016 | 129 | 0.030 |
Why?
| | Intestinal Obstruction | 1 | 1996 | 48 | 0.030 |
Why?
| | Area Under Curve | 1 | 2016 | 292 | 0.030 |
Why?
| | Postoperative Period | 1 | 2016 | 325 | 0.030 |
Why?
| | Matched-Pair Analysis | 1 | 2015 | 45 | 0.030 |
Why?
| | Radiologic Health | 1 | 2015 | 5 | 0.030 |
Why?
| | Titanium | 1 | 2015 | 80 | 0.030 |
Why?
| | Practice Guidelines as Topic | 2 | 2015 | 1537 | 0.030 |
Why?
| | Curettage | 1 | 2014 | 9 | 0.030 |
Why?
| | Rotation | 1 | 2015 | 118 | 0.030 |
Why?
| | Esthetics | 1 | 2015 | 51 | 0.030 |
Why?
| | Transplantation, Autologous | 1 | 2015 | 215 | 0.030 |
Why?
| | Medical Records | 1 | 2015 | 171 | 0.030 |
Why?
| | Skull | 1 | 1996 | 130 | 0.030 |
Why?
| | Lysholm Knee Score | 1 | 2014 | 8 | 0.030 |
Why?
| | Trauma Severity Indices | 1 | 2015 | 109 | 0.030 |
Why?
| | Pain Management | 1 | 2018 | 322 | 0.030 |
Why?
| | Cost Savings | 1 | 2015 | 83 | 0.030 |
Why?
| | ROC Curve | 1 | 2016 | 507 | 0.030 |
Why?
| | Coxa Valga | 1 | 2014 | 1 | 0.030 |
Why?
| | Edema | 1 | 1995 | 128 | 0.030 |
Why?
| | Immobilization | 1 | 2014 | 44 | 0.030 |
Why?
| | Regional Blood Flow | 1 | 2016 | 463 | 0.030 |
Why?
| | Occupational Therapy | 1 | 2015 | 85 | 0.030 |
Why?
| | Age Distribution | 1 | 2015 | 379 | 0.030 |
Why?
| | Finite Element Analysis | 1 | 2014 | 72 | 0.030 |
Why?
| | Physical Examination | 1 | 2015 | 238 | 0.030 |
Why?
| | Sex Distribution | 1 | 2015 | 361 | 0.030 |
Why?
| | Face | 1 | 1995 | 168 | 0.030 |
Why?
| | Osteoarthritis, Hip | 1 | 2014 | 43 | 0.030 |
Why?
| | Hospitalization | 1 | 2023 | 2094 | 0.030 |
Why?
| | Preoperative Care | 1 | 2015 | 343 | 0.030 |
Why?
| | Injections, Intra-Articular | 1 | 2012 | 45 | 0.030 |
Why?
| | Anti-Inflammatory Agents | 1 | 1996 | 475 | 0.020 |
Why?
| | Anesthetics, Local | 1 | 2012 | 85 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2012 | 274 | 0.020 |
Why?
| | Disease Management | 1 | 2015 | 597 | 0.020 |
Why?
| | Quality of Life | 1 | 2023 | 2735 | 0.020 |
Why?
| | Biopsy | 1 | 2014 | 1107 | 0.020 |
Why?
| | Patient Selection | 1 | 2014 | 678 | 0.020 |
Why?
| | Communication | 1 | 2016 | 844 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2012 | 766 | 0.020 |
Why?
| | Quality Improvement | 1 | 2018 | 1111 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1291 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 2012 | 518 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 1983 | 0.020 |
Why?
| | Lung | 1 | 2001 | 3967 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 5400 | 0.020 |
Why?
| | Acute-Phase Proteins | 2 | 1996 | 67 | 0.020 |
Why?
| | Aged | 2 | 2022 | 22282 | 0.020 |
Why?
| | Critical Care | 1 | 2010 | 559 | 0.020 |
Why?
| | Inflammation | 1 | 1996 | 2721 | 0.010 |
Why?
| | Length of Stay | 1 | 2010 | 1135 | 0.010 |
Why?
| | Orosomucoid | 1 | 1995 | 6 | 0.010 |
Why?
| | Telemetry | 1 | 1995 | 40 | 0.010 |
Why?
| | Hematocrit | 1 | 1995 | 94 | 0.010 |
Why?
| | Haptoglobins | 1 | 1995 | 51 | 0.010 |
Why?
| | Blood Volume | 1 | 1995 | 61 | 0.010 |
Why?
| | Mandible | 1 | 1995 | 64 | 0.010 |
Why?
| | Morbidity | 1 | 1996 | 302 | 0.010 |
Why?
| | Rectal Neoplasms | 1 | 1996 | 136 | 0.010 |
Why?
| | Colitis, Ulcerative | 1 | 1996 | 114 | 0.010 |
Why?
| | Fibrinogen | 1 | 1995 | 159 | 0.010 |
Why?
| | C-Reactive Protein | 1 | 1995 | 396 | 0.010 |
Why?
| | Crohn Disease | 1 | 1996 | 211 | 0.010 |
Why?
|
|
Carry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|